Ocular Therapeutix (OCUL) Non-Current Assets (2013 - 2026)

Ocular Therapeutix has reported Non-Current Assets for 14 years, with the latest figure at $26.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 45.58% year-over-year to $26.5 million; the trailing twelve-month figure through Mar 2026 stood at $94.3 million (up 32.78% YoY), and the FY2025 full-year result was $25.9 million, up 52.99% from the prior year.
• Non-Current Assets for Q1 2026 stood at $26.5 million, up from $25.9 million in the prior quarter.
• The five-year high for Non-Current Assets was $26.5 million in Q1 2026, with the low at $12.7 million in Q2 2022.
• Average Non-Current Assets over 5 years is $19.2 million, with a median of $19.1 million recorded in 2024.
• Year-over-year, Non-Current Assets soared 71.35% in 2023 and retreated 17.84% in 2024.
• Tracing OCUL's Non-Current Assets over 5 years: stood at $19.7 million in 2022, then increased by 0.83% to $19.8 million in 2023, then dropped by 14.51% to $16.9 million in 2024, then soared by 52.99% to $25.9 million in 2025, then increased by 2.34% to $26.5 million in 2026.
• The last three Non-Current Assets figures came in at $26.5 million (Q1 2026), $25.9 million (Q4 2025), and $23.9 million (Q3 2025), per Business Quant data.

Peer Comparison